COUNCIL ON STRATEGIC RISKS (THE): federal contracts won
Federal contracts of $10,000 or more awarded to this company since October 2023 (FY2024), from USAspending.gov. UEI: Q2UCNLMLD7G4
1contracts won
$356,648total obligated
$356,648median contract
Oct 21, 2025most recent start
Agencies it works for
| Agency | Contracts | Obligated |
|---|---|---|
| Department of Defense | 1 | $356,648 |
Industries (NAICS)
| NAICS | Contracts | Obligated |
|---|---|---|
| 541714 Research and Development in Biotechnology (except Nanobiotechnology) | 1 | $356,648 |
Where it works
Recent contracts
| Contract | Winner | Agency | Obligated | Start |
|---|---|---|---|---|
| BIOLOGICAL TECHNOLOGIES OFFICEWIDE
HR001126CE009 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Washington, DC |
— | Department of Defense Defense Advanced Research Projects Agency |
$356,648 Potential value: $692,875 |
Oct 21, 2025 Ends: Feb 20, 2028 |
Source: USAspending.gov (prime contract awards of $10,000 or more). Values are amounts obligated to date. Recent months can still change as agencies report late.